Try our mobile app

Allergan Aesthetics to Present Data from Its Leading Aesthetic Portfolio at the 2022 American Society for Dermatologic Surgery Meeting

Published: 2022-10-07 18:05:00 ET
<<<  go to ABBV company page

–Data results shared across facial injectables, body contouring and skincare portfolio highlights Allergan Aesthetics' continued commitment to advancing aesthetic medicine–Analyses of 15 years of post-marketing surveillance data demonstrate the global reported rate of delayed-onset nodules associated with dermal fillers on the Vycross technology platform is low (